Integrated Care for Pediatric Obesity Using Telehealth

Status Completed

Clinical Trial Summary

Obesity is perhaps the most urgent public health crisis in pediatrics. Thus, managing childhood obesity is a top priority among pediatricians in primary care settings. However, effective treatment typically is multidisciplinary, and most practices currently do not have the infrastructure for coordinating integrated care. With the advent of the Affordable Care Act (ACA), innovative systems for building multidisciplinary teams to provide integrated care through a patient-centered medical home will be at a strategic advantage. The use of electronic technologies for delivering health-related information or services, known as telehealth, is an innovation with the potential to streamline integrated care and transform interventions for chronic diseases. We propose a pilot study to evaluate telehealth for treating pediatric obesity in collaboration with a community practice (Wareham Pediatrics).

Patients aged 10 to 17 years who participate in the telehealth intervention study (N=40) will be randomly assigned to an "immediate" intervention group or a "wait list" control group. Subjects in the "immediate" intervention group will begin the 6-month telehealth intervention at the time of enrollment in the study and then receive general patient/family counseling from their primary care providers (PCPs) at routine office visits during a 6-month follow-up period. Those in the "wait list" control group will receive general patient/family counseling from their PCPs for 6 months followed by the telehealth intervention for 6 months. Thus, the total duration of participation in the study for each subject will be 12 months. The telehealth intervention will include dietary, physical activity, and behavioral management counseling provided by videoconferencing from the OWL clinical providers at Boston Children's Hospital to children in their homes, or at a telehealth station at Wareham Pediatrics.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01794546
Study type	Interventional
Source	Children's Hospital Boston
Contact
Status	Completed
Phase	N/A
Start date	February 2013
Completion date	January 2015

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03994419` - PErioperAtive CHildhood ObesitY
Recruiting	`NCT06111040` - Nurturing Needs Study: Parenting Food Motivated Children	N/A
Completed	`NCT03036696` - The BEACH Interview Study- Pregnant and Breastfeeding Mothers
Not yet recruiting	`NCT02484612` - Exercise Intensity and Appetite in Adolescents	N/A
Completed	`NCT02959034` - Pediatric Metabolism and Microbiome Repository
Completed	`NCT02545764` - Training Induced Reduction of Lower-limb Joint Loads During Locomotion in Obese Children	N/A
Recruiting	`NCT02426346` - A Scalable Weight Control Intervention for Adolescents	Phase 2
Completed	`NCT02160847` - Development of the DRIVE Curriculum to Address Childhood Obesity Risk Factors	N/A
Completed	`NCT01989065` - Healthy Lifestyles Program for You (HLP4U): Augmenting Childhood Obesity Treatment.	N/A
Completed	`NCT02375490` - Healthy Start to Increase Physical Activity and Improve Healthy Eating in Early Childcare Centres	N/A
Completed	`NCT01908153` - Taste Reward Processing in Pediatric Obesity
Completed	`NCT02343588` - A National School-based Health Lifestyles Interventions Among Chinese Children and Adolescents Against Obesity	N/A
Completed	`NCT02074332` - Study on Obesity Intervention With Physical Exercise Among Students in Changping District, Beijing	N/A
Completed	`NCT02086851` - Study of a Structured Parent Intervention on Adolescent Weight Loss Modification Program.	N/A
Terminated	`NCT00846521` - Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity	Phase 4
Completed	`NCT01146314` - A Family Based Intervention to Reduce the Risk of Type 2 Diabetes in Children	N/A
Completed	`NCT04164277` - FirstStep2Health Intervention	N/A
Withdrawn	`NCT04600648` - Sweet Taste Responsiveness in Relation to Insulin, Leptin and Adiposity Among Obese Treatment Seeking Children	N/A
Completed	`NCT04395430` - A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19	N/A
Completed	`NCT03139877` - Pediatric Obesity Observational Prospective Trial

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.